Theorem expands worldwide operations; Carestream sells imaging unit to Bruker;

> Theorem Clinical Research has expanded its worldwide staffing services to more than 30 countries around the globe. News

> Icon is expanding its leadership team, appointing vice presidents for the Asia Pacific and Latin America wings of its business. Report

> Open-source drug development could sap the profits of some CROs, according to a study. More

> Carestream has sold its preclinical imaging unit to Bruker. Neither company disclosed financial terms. Article

> Switzerland's DKSH has signed a deal with Astellas to distribute the company's drugs in Taiwan. Story

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.